Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Pharmacokinetics and Safety Following a Single Oral Dose of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

NCT05012436 is registered in ClinicalTrials.gov with Yuhan Corporation as lead sponsor.

NCT NCT05012436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05012436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Pharmacokinetics and Safety Following a Single Oral Dose of YHD1119 in Subjects With Renal Impairment and Healthy Subjects
Lead sponsor
Yuhan Corporation
Phase
Phase 1
Overall status
Completed
Start date
July 24, 2021
Completion date
May 10, 2022
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteer, renal impairments